Introduction: Extractable & Leachable Testing for Clinical to Commercial Scale-Up is essential because changes introduced during manufacturing scale-up can alter […]
Introduction Designing a GMP-Compliant Extractables and Leachables (E&L) Study for container closure systems requires a systematic, risk-tiered analytical framework to
Introduction Extractables and Leachables (E&L) Requirements for Single-Use Bioprocessing in cell therapy programs define the analytical frameworks and risk assessment
Introduction Outsourcing Extractables and Leachables (E&L) Testing to a Drug Establishment License (DEL) holder ensures that analytical data is generated
Introduction Achieving Extractables and Leachables (E&L) Compliance for a Dry Powder Inhaler intended for European Medicines Agency (EMA) approval demands
Introduction: Extractables and Leachables Testing for Prefilled Syringes has become an essential requirement for pharmaceutical companies developing injectable biologics, biosimilars,
Introduction Method Validation for Leachables Testing in a Good Manufacturing Practice (GMP) laboratory provides documented, objective evidence that an analytical
Method Validation for Leachables Testing: What Regulators Expect from a GMP Lab Read More »
Introduction Producing audit-ready Extractables and Leachables (E&L) data depends on a scientifically defensible, cGMP-compliant testing architecture capable of proving that
Introduction Container closure elastomers are considered one of the most significant sources of extractables and leachables in pharmaceutical packaging. Their
Introduction: GMP Data Integrity for Extractables and Leachables Testing has become one of the most important compliance requirements in pharmaceutical
Data Integrity and 21 CFR Part 11 in a GMP Extractables and Leachables Lab Read More »
